Fulvio Brema

1.1k total citations
36 papers, 562 citations indexed

About

Fulvio Brema is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Fulvio Brema has authored 36 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Genetics and 8 papers in Hematology. Recurrent topics in Fulvio Brema's work include Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Fulvio Brema is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Fulvio Brema collaborates with scholars based in Italy, United Kingdom and United States. Fulvio Brema's co-authors include Luciano Canobbio, G Pastorino, Francesco Boccardo, L. Santi, Cinzia Martini, Paolo Bruzzi, Franco Testore, P. Pronzato, Franco Patrone and Riccardo Rosso and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.

In The Last Decade

Fulvio Brema

36 papers receiving 531 citations

Peers

Fulvio Brema
Akihiro Ohmoto Japan
R Nissen-Meyer Norway
D F Hayes United States
Ram Chillar United States
W. Mattsson Sweden
J. Crawford United States
Ayako Mitsuma Japan
C Gilbert United States
Michelle Afkhami United States
Cyril Foa France
Akihiro Ohmoto Japan
Fulvio Brema
Citations per year, relative to Fulvio Brema Fulvio Brema (= 1×) peers Akihiro Ohmoto

Countries citing papers authored by Fulvio Brema

Since Specialization
Citations

This map shows the geographic impact of Fulvio Brema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvio Brema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvio Brema more than expected).

Fields of papers citing papers by Fulvio Brema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fulvio Brema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvio Brema. The network helps show where Fulvio Brema may publish in the future.

Co-authorship network of co-authors of Fulvio Brema

This figure shows the co-authorship network connecting the top 25 collaborators of Fulvio Brema. A scholar is included among the top collaborators of Fulvio Brema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulvio Brema. Fulvio Brema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murialdo, Roberto, G Pastorino, Manlio Mencoboni, et al.. (2011). Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial. Cancer Chemotherapy and Pharmacology. 68(4). 1009–1016. 3 indexed citations
2.
Venturini, Marco, Lucia Del Mastro, Enrico Aitini, et al.. (2005). Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(23). 1724–1733. 107 indexed citations
3.
Brema, Fulvio, et al.. (2004). Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer. Gynecologic Oncology. 93(2). 474–478. 10 indexed citations
4.
5.
Ballestrero, Alberto, Fabio Ferrando, Anna Garuti, et al.. (1997). High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule. British Journal of Cancer. 76(6). 797–804. 12 indexed citations
6.
Boccardo, Francesco, D. Amoroso, Stefano Iacobelli, et al.. (1997). Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study. Annals of Oncology. 8(8). 745–750. 6 indexed citations
7.
8.
Miglietta, Loredana, D. Amoroso, Milena Bruzzone, et al.. (1997). Paclitaxel plus Ifosfamide in Advanced Ovarian Cancer. Oncology. 54(2). 102–107. 13 indexed citations
9.
Patrone, Franco, Alberto Ballestrero, Fabio Ferrando, et al.. (1995). Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.. Journal of Clinical Oncology. 13(4). 840–846. 30 indexed citations
10.
Amoroso, D., Francesco Boccardo, Loredana Miglietta, et al.. (1995). Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: Results of a multicentric phase II trial. Breast Cancer Research and Treatment. 33(3). 265–268. 2 indexed citations
11.
Ardizzoni, Andrea, M. Venturini, M.R. Sertoli, et al.. (1994). Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer. British Journal of Cancer. 69(2). 385–391. 58 indexed citations
12.
Baldini, Editta, G. Gardin, P. Pronzato, et al.. (1993). Stimulation of Human Breast Cancer in Vivo. Annals of the New York Academy of Sciences. 698(1). 418–422. 3 indexed citations
13.
Sobrero, Alberto, Maria Teresa Nobile, Alfredo Guglielmi, et al.. (1992). Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer. European Journal of Cancer. 28(4-5). 850–852. 15 indexed citations
14.
Boccardo, Francesco, et al.. (1990). Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer. Journal of Cancer Research and Clinical Oncology. 116(5). 503–506. 22 indexed citations
15.
Pronzato, P., Fulvio Brema, D. Amoroso, et al.. (1990). Megestrol acetate: Phase II study of a single daily administration in advanced breast cancer. Breast Cancer Research and Treatment. 17(1). 51–54. 10 indexed citations
16.
Gasparini, Giampietro, Luciano Canobbio, Enzo Galligioni, et al.. (1987). Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: Therapeutic and endocrine effects in postmenopausal advanced breast cancer patients. European Journal of Cancer and Clinical Oncology. 23(10). 1451–1459. 10 indexed citations
17.
Nobile, Maria Teresa, et al.. (1984). Phase II Study of Ifosfamide Combined with Mesna Uroprotection in Advanced Non-Small-Cell Lung Carcinoma and Other Solid Tumors. Tumori Journal. 70(5). 433–437. 3 indexed citations
18.
Brema, Fulvio, Luciano Canobbio, Paolo Bruzzi, et al.. (1981). Hematologic Parameters during Treatment with High-Dose Medroxyprogesterone Acetate. Tumori Journal. 67(2). 125–128. 7 indexed citations
19.
Patrone, Franco, Franco Dallegri, Fulvio Brema, & C. Sacchetti. (1979). In Vitro Function of Chronic Myelocytic Leukemia Granulocytes. Effects of Irradiation and Storage. Tumori Journal. 65(1). 27–37. 6 indexed citations
20.
Patrone, Franco, Franco Dallegri, Fulvio Brema, & C Sacchetti. (1979). Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation.. PubMed. 7(3). 131–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Ohmoto Breakdown of academic impact, for papers by R Nissen-Meyer Breakdown of academic impact, for papers by D F Hayes Breakdown of academic impact, for papers by Ram Chillar Breakdown of academic impact, for papers by W. Mattsson Breakdown of academic impact, for papers by J. Crawford Breakdown of academic impact, for papers by Ayako Mitsuma Breakdown of academic impact, for papers by C Gilbert Breakdown of academic impact, for papers by Michelle Afkhami Breakdown of academic impact, for papers by Cyril Foa
Rankless by CCL
2026